NCT03329755View on ClinicalTrials.gov

Optimization of the Patient Care Pathway in Immuno-oncology

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

December 26, 2017

Primary Completion Date

February 19, 2021

Study Completion Date

February 19, 2021

Conditions
Melanoma
Interventions
OTHER

Dedicated and coordinated e-follow-up during the treatment period

"* Completion of questionnaires using an electronic tool~* Telephone follow-up between the nurse and the patient~* Completion of the Quality of Life Questionnaire Core 30 (QLQ-C30)"

OTHER

Standard follow-up during the treatment period

\- Completion of the Quality of Life Questionnaire Core 30 (QLQ-C30)

Trial Locations (2)

31059

Institut claudius regaud IUCT ONCOPOLE, Toulouse

33076

Hôpital Saint André, CHU de Bordeaux, Bordeaux

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT03329755 - Optimization of the Patient Care Pathway in Immuno-oncology | Biotech Hunter | Biotech Hunter